肌电压力一体化电刺激联合生物反馈治疗女性轻中度压力性尿失禁的临床疗效及对盆底肌功能的影响：一项前瞻性研究-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

肌电压力一体化电刺激联合生物反馈治疗女性轻中度压力性尿失禁的临床疗效及对盆底肌功能的影响：一项前瞻性研究

To investigate the clinical efficacy of integrated electromyographic pressure electrical stimulation combined with biofeedback in the treatment of mild to moderate female stress urinary incontinence and its effect on pelvic floor muscle function: a prospective study

ES评分 0 浏览量：341 下载量：0

全文阅读下载引用收藏

DOI	10.12208/j.ijcr.20260016
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2026, 10(1)
作者	邸欣¹, 李海燕², 刘媛媛¹, 路静¹, 宋艳茹¹, 闫炜²,
作者单位	1 石家庄市鹿泉区妇幼保健院河北石家庄 2 南京麦澜德医疗技术研究院江苏南京
摘要	目的探讨肌电压力一体化电刺激联合生物反馈治疗对改善女性轻中度压力性尿失禁症状、生活质量及盆底肌功能等方面的临床疗效。方法该研究最终纳入79名被诊断为轻中度压力性尿失禁的女性患者，平均年龄（34.59±7.09）岁，平均病程（17.20±9.80）个月，平均BMI（22.80±3.20）kg/m2，所有患者均接受肌电压力一体化电刺激联合生物反馈治疗，刺激频率15-60Hz，每周3次，每次治疗30分钟；连续5周，共完成15次治疗。观察治疗前（T0）、治疗结束后（T1）及随访（治疗结束后3个月，T2）不同时间节点国际尿失禁咨询委员会尿失禁问卷简表（ICI-Q-SF）、尿失禁影响问卷简版（IIQ-7）、盆底肌电/压力等指标治疗前后变化。结果 ICI-Q-SF评分从7.15±3.49分（T0）降至0.92±2.51分（T1）、2.20±1.00分（T2）（T1、T2与T0相比较，P<0.05）；临床总有效率为86.1%，治愈率为83.5%；IIQ-7总分从2.89±3.61分（T0）升至0.38±1.20分（T1）和0.28±1.30分（T2）（T1、T2与T0相比较，P<0.05）；盆底肌电/压力评估，盆底肌电总得分从基线（T0）51.01±13.70分提高至治疗结束后（T1）61.86±12.15分，提高幅度为21.3%（P<0.05）；前静息阶段平均值从8.27±5.42μV（T0）降至5.19±3.80μV（T1），降低幅度为37.2%（P<0.05）；I型肌纤维平均值从34.92±20.67μV（T0）提高至37.48±16.70μV（T1），提高幅度为7.3%（P<0.05）；II型肌纤维压力最大值从5.64±4.37cmH2O（T0）提高至8.30±5.65cmH2O（T1），提高幅度为47.2%（P<0.05）；I型肌纤维压力平均值从4.49±3.54cmH2O（T0）提高至7.50±5.04cmH2O（T1），提高幅度为67.0%（P<0.05）；I型肌纤维变异性从0.23±0.10降至0.18±0.08，提示I型肌纤维收缩的稳定性提升幅度为21.7%（P<0.05）；I型肌纤维恢复时间从1.28±1.03s缩短至0.90±0.54s（P<0.05），反映肌肉疲劳恢复能力的改善幅度为29.7%；初始肌电值从8.57±5.55μV降至6.72±4.42μV（P<0.05），耐受肌电值从16.19±8.73μV降至10.44±6.27μV（P<0.05）。治疗结束后（T1），总得分、前静息阶段平均值、II型肌纤维上升时间、I型肌纤维平均值、I型肌纤维恢复时间、II型肌纤维压力最大值、I型肌纤维压力平均值等关键指标均较治疗前显著改善（P<0.05），而II型肌纤维最大值、最大耐受压力值等相关指标治疗前后无显著差异（P>0.05）。结论肌电压力一体化电刺激联合生物反馈治疗不仅能够显著缓解尿失禁症状，提高生活质量，还能优化盆底肌功能。
Abstract	Objective To investigate the clinical efficacy and safety of integrated electromyographic pressure electrical stimulation combined with biofeedback therapy in improving symptoms, pelvic floor muscle function, and quality of life in women with mild to moderate stress urinary incontinence. Methods The study included 79 women diagnosed with mild-to-moderate stress urinary incontinence, the average age was (34.59±7.09) years, the average disease duration was (17.20±9.80) months, and the average BMI was (22.80±3.20) kg/m2.all of them received integrated electromyographic pressure electrical stimulation combined with biofeedback therapy, the stimulation frequency is 15-60Hz, three times a week, with each treatment lasting 30 minutes. A total of 15 treatments were completed for 5 consecutive weeks. Before treatment (T0), after treatment (T1) and follow-up (3 months after treatment, T2) at different time points, the International Consultative Committee on Urinary Incontinence Questionnaire short form (ICI-Q-SF), Incontinence Impact questionnaire short form (IIQ-7), pelvic floor electromyograph/pressure and other indicators were observed before and after treatment. Results The ICI-Q-SF score decreased from 7.15±3.49 points (T0) to 0.92±2.51 points (T1) and 2.20±1.00 points (T2) (compared with T0, T1 and T2, P <0.05). The total clinical effective rate was 86.1%, among which the cure rate was 83.5%. The total score of IIQ-7 increased from 2.89± 3.61 points (T0) to 0.38± 1.20 points (T1) and 0.28± 1.30 points (T2) (compared with T0, T1 and T2, P <0.05). Pelvic floor electromyography/pressure assessment: The total score of pelvic floor electromyography increased from 51.01±13.70 points at baseline (T0) to 61.86±12.15 points at the end of treatment (T1), with an increase of 21.3% (P<0.05). The average value of the pre-resting stage decreased from 8.27±5.42μV (T0) to 5.19±3.80μV (T1), with a decrease of 37.2%(P<0.05). The average value of type I muscle fibers increased from 34.92±20.67μV (T0) to 37.48±16.70μV (T1), with an increase of 7.3% (P<0.05). The maximum pressure of type II muscle fibers increased from 5.64±4.37cmH2O (T0) to 8.30±5.65 cmH2O (T1), with an increase of 47.2% (P<0.05). The average pressure of type I muscle fibers increased from 4.49±3.54cmH2O (T0) to 7.50±5.04 cmH2O (T1), with an increase of 67.0% (P<0.05). The variability of type I muscle fibers decreased from 0.23±0.10 to 0.18±0.08, suggesting that the stability improvement of type I muscle fiber contraction was 21.7% (P<0.05). The recovery time of type I muscle fibers was shortened from 1.28±1.03s to 0.90±0.54s (P<0.05), reflecting an improvement range of 29.7% in muscle fatigue recovery ability. The initial electromyography (EMG) value decreased from 8.57±5.55μV to 6.72±4.42μV (P<0.05), and the tolerated EMG value decreased from 16.19±8.73μV to 10.44±6.27μV (P<0.05). After treatment (T1), key indicators such as the total score, the average value of the pre-resting stage, the rise time of fast muscle, the average value of slow muscle, the recovery time of slow muscle, the maximum value of fast muscle pressure, and the average value of slow muscle pressure were significantly improved compared with those before treatment (P<0.05), while there were no significant differences in related indicators such as the maximum value of fast muscle and the maximum tolerable pressure value before and after treatment (P>0.05). Conclusion Integrated electromyographic pressure electrical stimulation combined with biofeedback therapy can not only significantly relieve the symptoms of urinary incontinence, improve the quality of life, but also optimize the pelvic floor muscle function.
关键词	肌电压力一体化电刺激；生物反馈；压力性尿失禁；盆底肌功能
KeyWord	Integrated electromyographic pressure electrical stimulation; Biofeedback; Stress urinary incontinence; Pelvic floor muscle function
基金项目
页码	58-65

参考文献
相关文献

[1] Zhu J, Pang H, Wang P, et al. Female urinary incontinence in China after 15 years' efforts: Results from large-scale nationwide surveys
[J]. Sci Bull (Beijing), 2024, 69:3272-3282.

[2] Li L, Li G, Dai S, et al. Prevalence and spatial distribution characteristics of female stress urinary incontinence in mainland China
[J]. Eur Urol Open Sci, 2024, 68:48-60.

[3] Moris L, Heesakkers J, Nitti V, et al. Prevalence, diagnosis, and management of stress urinary incontinence in women: a collaborative review
[J]. Eur Urol, 2025, 87:292-301.

[4] Carlson K, Andrews M, Bascom A, et al. 2024 Canadian Urological Association guideline: Female stress urinary incontinence
[J]. Can Urol Assoc J, 2024, 18: 83-102.

[5] Xue K, Palmer MH, Zhou F. Prevalence and associated factors of urinary incontinence in women living in China: a literature review
[J]. BMC Urol, 2020, 20: 159.

[6] Shek KL, Kruger J, Dietz HP. The effect of pregnancy on hiatal dimensions and urethral mobility: an observational study
[J]. Int Urogynecol J, 2012,23:1561-1567.

[7] Dolan LM, Hilton P. Obstetric risk factors and pelvic floor dysfunction 20 years after first delivery
[J]. Int Urogynecol J, 2010, 21:535-544.

[8] 侯晓,李霞,孙群,等. 女性盆底功能障碍性疾病诊治流程及物理康复技术临床应用——定义、流行病学、发病机制及物理康复技术概要
[J].生殖医学杂志,2024,33: 277-282.

[9] Kopańska M, Torices S, Czech J, et al. Urinary incontinence in women: biofeedback as an innovative treatment method
[J]. Ther Adv Urol, 2020, 12: 1756287220934359.

[10] Hwang JC, Sun FJ, Su TH,et al.Efficacy of biofeedback and Electrostimulation-Assisted Pelvic Floor Muscle Training between Women with Mild and Moderate to Severe Stress Urinary Incontinence
[J]. J Clin Med, 2022, 11: 6424.

[11] Huang Y, Huang Z, Ou Y, et al. Meta-analysis of the therapeutic effect of electrical stimulation combined with pelvic floor muscle exercise on female pelvic floor dysfunction
[J]. Eur J Med Res, 2024, 29: 380.

[12] Sarmento ALC, SáBS, Vasconcelos AG, et al. Perspectives on the therapeutic effects of pelvic floor muscle training and electrical stimulation: a systematic review
[J]. Int J Environ Res Public Health, 2022, 19: 14035.

[13] 夏雅芬,林芳,谢扬玉. 生物反馈电刺激联合凯格尔训练对产后压力性尿失禁患者漏尿症状及盆底肌力的影响
[J].慢性病学杂志,2024,25:621-623+627.

[14] 刘姣姣, 严文广, 唐源, 等. 本体感觉训练联合盆底电刺激生物反馈对产后盆底功能障碍的治疗效果
[J]. 中南大学学报(医学版), 2022, 47:1253-1259.

[15] Brubaker L, Benson JT, Bent A, et al. Transvaginal electrical stimulation for female urinary incontinence
[J]. Am J Obstet Gynecol, 1997, 177: 536-540.

[16] Hagen S, Elders A, Stratton S,et al. Effectiveness of pelvic floor muscle training with and without electromyographic biofeedback for urinary incontinence in women: multicentre randomised controlled trial
[J]. BMJ,2020, 371:m3719.

[17] 刘盼,刘彩娥,唐桂艳,等. 女性盆底功能障碍性疾病诊治流程及物理康复技术临床应用——临床评估与诊断
[J].生殖医学杂志,2024,33:419-425.

[18] CHEN F,ZHOU J,WU W,et al. Study on the therapeutic effect of floating needle therapy combined with pressing acupoint embedding for female stress urinary incontinence after childbirth:A randomized trial
[ J ] . Ann Palliat Med,2021,10 ( 7 ):7786- 7793.

[19] 盆底功能障碍评估与干预技术多学科共识专家组. 盆底功能多模态评估体系的专家共识
[J]. 中国循证医学杂志,2024,24:869-874.

[20] Galasso A, Urits I, An D, et al. A comprehensive review of the treatment and management of myofascial pain syndrome
[J]. Curr Pain Headache Rep, 2020, 24: 43.

[21] Aung HH, Dey L, Rand V, et al. Alternative therapies for male and female sexual dysfunction
[J]. Am J Chin Med, 2004, 3: 161-173.

[22] 张华, 李丽, 王沛华, 等. 医院 - 家庭一体化盆底肌训练对产后盆底功能障碍的康复效果观察
[J]. 现代医学与健康研究, 2025, 9:30- 32.

[23] 叶绮婷,吴斯琪,何嘉慧,等. 实时三维盆底超声在电刺激生物反馈联合盆底肌锻炼治疗初产妇顺产后压力性尿失禁疗效评估中的临床价值
[J].中华保健医学杂志, 2025, 27: 318-322.

[24] 郝伶俐,韩梅,赫永磊,等. 仿生物电刺激联合认知行为疗法对女性压力性尿失禁患者的效果评价
[J].中国医药, 2024,19:1047-1051.

[25] 谢琴,齐兴盛,王蔚. 盆底磁刺激联合生物反馈盆底肌康复治疗
[J]. 实用妇科内分泌电子杂志, 2022, 9: 73-75.

[26] Elena S, Dragana Z, Ramina S, et al. Electromyographic evaluation of the pelvic muscles activity after high-intensity focused electromagnetic procedure and electrical stimulation in women with pelvic floor dysfunction
[J]. J Sex Med, 2020, 8: 282-289.

引用本文

邸欣, 李海燕, 刘媛媛, 路静, 宋艳茹, 闫炜. 肌电压力一体化电刺激联合生物反馈治疗女性轻中度压力性尿失禁的临床疗效及对盆底肌功能的影响：一项前瞻性研究 [J]. 国际临床研究杂志. 2026; 10; (1). 58 - 65.

文献评论

相关学者

相关机构